Skip to content

Concussion Prevention in Female Soccer Athletes

Novel Protection Against Potential Brain Injury During Competitive Non-helmeted Sport in Females

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03014492
Enrollment
72
Registered
2017-01-09
Start date
2016-06-30
Completion date
2018-07-31
Last updated
2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concussion, Brain, Concussion, Mild

Brief summary

The purpose of the study is to monitor longitudinal changes in brain structure and function between the preseason and postseason, in a population of soccer playing athletes wearing the Device and compared to a similar population not wearing the device. Secondly, the purpose is to determine the protection of the device relative to amount and magnitude of sustained head impacts.

Detailed description

This study will investigate the effectiveness of this device in high school athletes playing a non-helmeted sport such as soccer. Athletes participating in this study will be randomly assigned to one of two groups: 1) Device wearing during the season or 2) Non-device wearing during the season. This study will focus on the use and effectiveness of the device solely in females, as male football and hockey players have previously been investigated. All participants will be outfitted with an adhesive patch-like accelerometer (which will be placed behind the ear (Xpatch-X2 Biosystems http://www.x2biosystems.com/x2\_x\_patch/) which will measure the magnitude of every impact to the head sustained by the athlete. Effectiveness of the device will be determined via differences in longitudinal brain imaging and functional testing following competitive soccer participation. A subset of athletes who report a diagnosed concussion will also receive additional brain neuroanatomical and neurophysiological testing within a week following the diagnosed concussive event. At each of these time points participants will also undergo various neurocognitive assessments

Interventions

DEVICEQ Collar

Collar designed to mitigate slosh in the brain

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * Normal healthy volunteer * Able to provide written consent * Must be 14 years or older and a participant on a high school soccer team

Exclusion criteria

* Unable to provide written consent * History of neurological deficits, previous cerebral infarction, or severe head trauma as indicated through pre-season screening: * Medical contraindications to restriction of venous outflow via the internal jugular veins (known increased intracerebral pressure, metabolic acidosis or alkalosis) * Glaucoma (Narrow Angle or Normal Tension) * Hydrocephalus * Recent penetrating brain trauma (within 6 months) * Known carotid hypersensitivity * Known increased intracranial pressure * Central vein thrombosis * Any known airway obstruction * Any known seizure disorder

Design outcomes

Primary

MeasureTime frameDescription
Pre-season to Post-season DTI Percentage Change6 monthsDetermine % changes in brain structure between pre-season and post-season in AD, axial diffusivity; FA, fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity.
Number of Participants Completing EEG6 monthsNumber of participants completing EEG

Countries

United States

Participant flow

Participants by arm

ArmCount
Collar Group
Soccer girls that wore the collar device Q Collar: Collar designed to mitigate slosh in the brain
44
No Collar Group
soccer girls that did not wear the collar
28
Total72

Baseline characteristics

CharacteristicCollar GroupNo Collar GroupTotal
Age, Categorical
<=18 years
44 Participants28 Participants72 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age of participant16.06 years
STANDARD_DEVIATION 1.1
15.95 years
STANDARD_DEVIATION 1.04
16.0 years
STANDARD_DEVIATION 1.07
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
44 participants28 participants72 participants
Sex: Female, Male
Female
44 Participants28 Participants72 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 440 / 28
other
Total, other adverse events
0 / 440 / 28
serious
Total, serious adverse events
0 / 440 / 28

Outcome results

Primary

Number of Participants Completing EEG

Number of participants completing EEG

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Collar GroupNumber of Participants Completing EEG44 Participants
No Collar GroupNumber of Participants Completing EEG28 Participants
Primary

Pre-season to Post-season DTI Percentage Change

Determine % changes in brain structure between pre-season and post-season in AD, axial diffusivity; FA, fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity.

Time frame: 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Collar GroupPre-season to Post-season DTI Percentage ChangeFA-0.17 percentage of changeStandard Deviation 1.99
Collar GroupPre-season to Post-season DTI Percentage ChangeMD0.45 percentage of changeStandard Deviation 2.23
Collar GroupPre-season to Post-season DTI Percentage ChangeAD0.37 percentage of changeStandard Deviation 2.23
Collar GroupPre-season to Post-season DTI Percentage ChangeRD0.53 percentage of changeStandard Deviation 2.72
No Collar GroupPre-season to Post-season DTI Percentage ChangeRD3.52 percentage of changeStandard Deviation 2.6
No Collar GroupPre-season to Post-season DTI Percentage ChangeFA-1.27 percentage of changeStandard Deviation 1.35
No Collar GroupPre-season to Post-season DTI Percentage ChangeAD2.58 percentage of changeStandard Deviation 2.34
No Collar GroupPre-season to Post-season DTI Percentage ChangeMD2.83 percentage of changeStandard Deviation 2.46

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026